BIO-TECHNE CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 76.91 USD | -2.29% |
|
+1.06% | +6.77% |
Chart calendar Bio-Techne Corporation
ee76fef3e51211caa36f8f575d7.2oxWCH1dlS0nj5XxGxnacC3QGGkUCaIJVxV8A68729g.qbgmYwcK80FQ-vyFKkGtNkbiWzBFUcxlL3wTNOx4s4ee9TJQMgfEZk_39g~2183b111b7358defa95cb69bbf5a06d3
Upcoming events on Bio-Techne Corporation
Past events on Bio-Techne Corporation
| 2025-01-22 11:00 am | Phacilitate Advanced Therapies Week |
| 2025-01-21 01:15 pm | Phacilitate Advanced Therapies Week - Breakout Session |
| 2025-01-14 01:30 pm | JP Morgan Healthcare Conference |
| 2024-12-04 03:15 pm | Citi Global Healthcare Conference |
| 2024-11-23 12:15 pm | Association for Molecular Pathology Meeting & Expo - Poster #G013 |
| 2024-11-23 12:15 pm | Association for Molecular Pathology Meeting & Expo - Poster G095 |
| 2024-11-22 12:15 pm | Association for Molecular Pathology Meeting & Expo - Poster G094 |
| 2024-11-22 12:15 pm | Association for Molecular Pathology Meeting & Expo - Poster #ID046 |
| 2024-11-20 08:15 pm | Association for Molecular Pathology Meeting & Expo - LDT Compliance in an Uncertain Environment |
| 2024-11-20 06:00 pm | Association for Molecular Pathology Meeting & Expo - ESR1 & Beyond Leveraging Exosomes for Highly-Se |
| 2024-11-20 03:00 pm | Association for Molecular Pathology Meeting & Expo - Long Range PCR Meets Long Read Sequencing: An A |
| 2024-11-20 12:00 pm | Stephens Investment Conference |
| 2024-11-19 08:00 am | Stifel Healthcare Conference |
| 2024-11-12 12:30 pm | UBS Global Healthcare Conference |
| 2024-11-09 08:10 pm | Society for Immunotherapy of Cancer Meeting - Poster #124 |
| 2024-11-09 08:10 pm | Society for Immunotherapy of Cancer Meeting - Poster #206 |
| 2024-11-09 08:10 pm | Society for Immunotherapy of Cancer Meeting - Poster #106 |
| 2024-11-09 08:00 pm | Society for Immunotherapy of Cancer Meeting - Poster #86 |
| 2024-11-09 02:45 pm | Society for Immunotherapy of Cancer Meeting - Poster #124 |
| 2024-11-09 01:15 pm | Society for Immunotherapy of Cancer Meeting - Poster #86 |
Past dividends on Bio-Techne Corporation
| 2024-11-07 | Quarterly 0.08 USD |
| 2024-08-18 | Quarterly 0.08 USD |
| 2024-05-09 | Quarterly 0.08 USD |
| 2024-02-08 | Quarterly 0.08 USD |
| 2023-11-08 | Quarterly 0.08 USD |
| 2023-08-16 | Quarterly 0.08 USD |
| 2023-05-11 | Quarterly 0.08 USD |
| 2023-02-09 | Quarterly 0.08 USD |
| 2022-11-09 | Quarterly 0.32 USD |
| 2022-08-11 | Quarterly 0.32 USD |
| 2022-05-12 | Quarterly 0.32 USD |
| 2022-02-09 | Quarterly 0.32 USD |
| 2021-11-09 | Quarterly 0.32 USD |
| 2021-08-12 | Quarterly 0.32 USD |
| 2021-05-13 | Quarterly 0.32 USD |
| 2021-02-10 | Quarterly 0.32 USD |
| 2020-11-12 | Quarterly 0.32 USD |
| 2020-08-16 | Quarterly 0.32 USD |
| 2020-05-07 | Quarterly 0.32 USD |
| 2020-02-12 | Quarterly 0.32 USD |
Annual results
| Fiscal Period | June | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1 106 1 108 -0.24% | 1 137 1 143 -0.51% | 1 159 1 159 -0.01% | 1 224 | 1 337 | 1 489 |
|
EBITDA Million USD | Released Forecast Spread | 449 449 0.14% | 441 446 -1.04% | 411 407 1.09% | 426 | 492 | 539 |
|
EBIT Million USD | Released Forecast Spread | 421 424 -0.67% | 410 412 -0.53% | 370 372 -0.42% | 386 | 447 | 500 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 301 294 2.64% | 339 331 2.36% | 186 209 -11.19% | 237 | 321 | 382 |
|
Net income Million USD | Released Forecast Spread | 272 270 0.74% | 285 274 4.06% | 168 180 -6.55% | 197 | 261 | 320 |
|
EPS USD | Released Forecast Spread | 1,66 1,64 1.22% | 1,76 1,69 4.05% | 1,05 1,12 -6.13% | 1,20 | 1,57 | 1,88 |
| Announcement Date | 04/08/22 | 08/08/23 | 07/08/24 | - |
Quarterly results
| Fiscal Period | September | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 294 299 -1.48% | 301 308 -2.26% | 277 288 -3.72% | 273 278 -1.85% | 303 293 3.65% | 306 306 -0.08% | 289 280 3.35% | 286 | 318 | 329 | 313 | 313 | 346 | 359 | 346 |
|
EBITDA Million USD | Released Forecast Spread | 116 117 -0.9% | 120 122 -1.32% | 95,6 99,1 -3.51% | 93,2 98,1 -4.92% | 109 103 5.74% | 111 112 -0.93% | 95,7 88,3 8.34% | 88,9 | 118 | 126 | 104 | 100 | 129 | 138 | 114 |
|
EBIT Million USD | Released Forecast Spread | 109 110 -1.33% | 112 114 -1.51% | 86,9 91,9 -5.41% | 81,9 87,2 -6.03% | 99,6 94,4 5.52% | 102 103 -1.4% | 83,2 79,3 5% | 79,9 | 107 | 116 | 96,5 | 91,4 | 119 | 129 | 105 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 80,2 77,2 3.92% | 88,3 80,5 9.71% | 49,6 61,1 -18.87% | 33,4 53,7 -37.86% | 61,1 56,0 9.09% | 41,7 63,6 -34.49% | 40,2 45,4 -11.56% | 45,0 | 72,1 | 78,5 | 62,4 | 61,4 | 85,9 | 93,6 | |
|
Net income Million USD | Released Forecast Spread | 70,2 63,1 11.3% | 75,5 64,0 17.92% | 51,0 47,1 8.25% | 27,5 43,3 -36.5% | 49,1 46,7 5.06% | 40,6 52,1 -22.17% | 33,6 35,5 -5.34% | 35,1 | 57,4 | 62,5 | 48,7 | 47,9 | 67,0 | 73,0 | |
|
EPS USD | Released Forecast Spread | 0,43 0,39 10.26% | 0,47 0,40 18.49% | 0,31 0,29 6.28% | 0,17 0,27 -35.85% | 0,31 0,29 7.64% | 0,25 0,33 -23.78% | 0,21 0,20 2.94% | 0,22 | 0,35 | 0,38 | 0,29 | 0,29 | 0,41 | 0,45 | |
| Announcement Date | 03/05/23 | 08/08/23 | 31/10/23 | 01/02/24 | 01/05/24 | 07/08/24 | 30/10/24 | - | - | - | - | - | - | - | - |
| 2025-01-28 | LONZA GROUP AG: Q4 2024 Earnings Release |
| 2025-02-05 06:30 am | BIO-TECHNE CORPORATION: Q2 2025 Earnings Release |
| 2025-02-05 04:05 pm | QIAGEN N.V.: Q4 2024 Earnings Release |
| 2025-02-05 | REPLIMUNE GROUP, INC.: Q3 2025 Earnings Release (Projected) |
| 2025-02-06 07:00 am | IQVIA HOLDINGS INC.: Q4 2024 Earnings Release |
| 2025-02-09 | MEDPACE HOLDINGS, INC.: Q4 2024 Earnings Release |
| 2025-02-10 | AZENTA, INC.: Q1 2025 Earnings Release (Projected) |
| 2025-02-11 | IMMUNOVANT, INC.: Q3 2025 Earnings Release (Projected) |
| 2025-02-11 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: Q4 2024 Earnings Release (Projected) |
| 2025-02-12 04:01 pm | GALAPAGOS NV: Q4 2024 Earnings Release |
Past sector events for Bio-Techne Corporation
| 2025-01-22 | SYNGENE INTERNATIONAL LIMITED: Q3 2025 Earnings Release |
| 2025-01-15 02:00 am | GENUS PLC: Q2 2025 Sales and Revenue Release - Trading Update |
| 2025-01-10 12:34 am | POLARIS GROUP: December 2024 Sales and Revenue Release |
| 2024-12-09 03:53 am | POLARIS GROUP: November 2024 Sales and Revenue Release |
| 2024-11-27 | FORMYCON AG: Q3 2024 Earnings Release |
| 2024-11-20 07:00 am | SEPTERNA, INC.: Q3 2024 Earnings Release |
| 2024-11-20 02:00 am | GENUS PLC: Q1 2025 Sales and Revenue Release - Trading Update |
| 2024-11-14 08:00 am | ARRIVENT BIOPHARMA, INC.: Q3 2024 Earnings Release |
| 2024-11-14 08:00 am | SILENCE THERAPEUTICS PLC: Q3 2024 Earnings Release |
| 2024-11-14 02:00 am | BIOARCTIC AB: Q3 2024 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- TECH Stock
- Calendar Bio-Techne Corporation